Updated
Updated · Healthline · Jun 30
Study Finds Under 1% of Statin Users Face High 10-Year Muscle-Risk
Updated
Updated · Healthline · Jun 30

Study Finds Under 1% of Statin Users Face High 10-Year Muscle-Risk

2 articles · Updated · Healthline · Jun 30

Summary

  • Less than 1% of statin users had a 10-year risk above 10% for serious muscle disorders, and only about 0.04% crossed that threshold in the new study.
  • More than 1.7 million electronic health records from England, covering men 50+ and women 60+ between 1998 and 2018, were used to model 1-, 5- and 10-year risks tied to hospitalization or death.
  • Researchers said the findings could counter fears that keep patients from treatment, noting statins can cut cholesterol by as much as 50% while fewer than half of 50 million eligible Americans take them.
  • Cardiologists cited in the report said the benefits in preventing heart disease and stroke usually outweigh the risks, though one expert stressed the study did not capture milder side effects that can still affect quality of life.

Insights

While serious statin risks are rare, should common side effects that diminish quality of life be dismissed?
With genetic testing for side effects now deemed unnecessary, what is the future of personalized statin therapy?
Could natural supplements like berberine become a mainstream alternative for the millions who are statin-intolerant?

Statin Safety in 2026: Landmark Studies, Personalized Risk Tools, and Separating Fact from Fiction

Overview

This report highlights how new research in June 2026 is reshaping our understanding of statin safety, especially regarding muscle-related side effects. It explains that while many people believe statins are more dangerous than they are, this misconception is fueled by social media, misinformation, and stories shared by others. To address these concerns, researchers have created new tools, like personalized risk calculators, to help patients and healthcare providers better understand the real risks and benefits of statin therapy. These efforts aim to support informed decisions and improve confidence in using statins for heart disease prevention.

...